News ArchivesRead News

’Engineered’ Stem Cells May Help Treat Parkinson’s

Thursday December 22, 2005

12/15/05(Forbes) - Engineered human progenitor brain stem cells are able to produce and deliver into the brain a growth factor that shows promise in treating Parkinson’s disease, say researchers at the University of Wisconsin-Madison.

A major challenge in treating Parkinson’s and other neurodegenerative brain disorders is getting drugs to the desired areas of the brain. The brain’s structure effectively blocks the delivery of most drugs via the bloodstream. The engineered progenitor brain cells are designed to sneak drugs past the blood-brain barrier.

The University of Wisconsin team obtained and grew large numbers of progenitor cells from human fetal brain tissue and engineered those cells to produce the growth factor called glial cell line-derived neurotrophic factor (GDNF).

Some small clinical trials showed that GDNF provide relief from the debilitating symptoms of Parkinson’s disease. However, GDNF could not cross the blood-brain barrier and had to be pumped directly into the brains of Parkinson’s patients in order to work.

In this latest study, researchers transplanted the engineered progenitor cells into the brains of rats and monkeys. The cells effectively integrated into the brains of the animals and delivered GDNF to the targeted brain areas.

The findings were published in the Dec. 15 issue of the journal Gene Therapy.

"This work shows that stem cells can be used as drug delivery vehicles in the brain," University of Wisconsin-Madison neuroscientist Clive Svendson said in a prepared statement.

Recent News

Sep 27 - The beginning of the end? The race for a Parkinson’s cure
Sep 22 - Understanding Parkinson's Disease: An Interview with Jon Palfreman
Sep 22 - Living with Lewy Body Dementia
Sep 21 - Adults with autism likely to develop Parkinson’s disease, says study
Sep 16 - Everyday activity more beneficial than occasional strenuous exercise for Parkinson’s disease
Sep 14 - UNC scientists create smarter immune cells to treat Parkinson's disease
Sep 9 - A newly discovered brain disease may point to something disturbing about Alzheimer’s and Parkinson’s
Sep 7 - Treatment for Parkinson's could replace surgery
Sep 4 - Asthma May Influence Risk of Parkinson's Disease
Sep 4 - Researchers Explore Memory Problems Related to Parkinson's
Sep 3 - Press Release: ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID™ for the Treatment of Parkinson’s Disease Psychosis
Aug 28 - Brain cells 'burn out' in Parkinson's disease
Aug 24 - Study Details Process Involved in Parkinson’s Disease
Aug 24 - Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Aug 20 - Two proteins work together to help cells eliminate trash; Parkinson's may result
Aug 17 - Scientists visualize critical part of basal ganglia pathways
Aug 17 - VA benefits office seeks all vets exposed to Agent Orange
Aug 12 - New, rapid dementia screening tool rivals 'gold standard' clinical evaluations
Aug 11 - Strolling in Seaside, fighting Parkinson's
Aug 11 - Scientists probing molecular origins of Parkinson's disease highlight two proteins